Paneth cells, defensins, and the commensal microbiota: A hypothesis on intimate interplay at the intestinal mucosa

Seminars in Immunology

Volumn 19, Issue 2, 2007, Pages 70-83

  Salzman, Nita H ^a   Underwood, Mark A ^b   Bevins, Charles L ^b  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Crohn's disease; Defensin; Intestine; Microbiota; Necrotizing enterocolitis

Indexed keywords

DEFENSIN; POLYPEPTIDE ANTIBIOTIC AGENT;

BACTERIAL COLONIZATION; COMMENSAL; CROHN DISEASE; ENTERITIS; GASTROINTESTINAL TRACT; GERMFREE ANIMAL; HOMEOSTASIS; HOST RESISTANCE; HUMAN; IMMUNE RESPONSE; INNATE IMMUNITY; INTESTINE FLORA; INTESTINE MUCOSA; NECROTIZING ENTEROCOLITIS; NONHUMAN; PANETH CELL; PREMATURITY; REVIEW;

ALPHA-DEFENSINS; ANIMALS; BACTERIAL PHYSIOLOGY; BETA-DEFENSINS; ENTEROCOLITIS, NECROTIZING; GERM-FREE LIFE; HUMANS; IMMUNITY, MUCOSAL; IMMUNITY, NATURAL; INFLAMMATORY BOWEL DISEASES; INTESTINAL MUCOSA; PANETH CELLS; SYMBIOSIS;

EID: 34249313567     PISSN: 10445323     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.smim.2007.04.002     Document Type: Review

References (143)

1. Hooper L.V., Midtvedt T., and Gordon J.I. How host-microbial interactions shape the nutrient environment of the mammalian intestine. Annu Rev Nutr 22 (2002) 283-307
2. Eckburg P.B., Bik E.M., Bernstein C.N., et al. Diversity of the human intestinal microbial flora. Science 308 5728 (2005) 1635-1638
3. Bik E.M., Eckburg P.B., Gill S.R., et al. Molecular analysis of the bacterial microbiota in the human stomach. Proc Natl Acad Sci USA 103 3 (2006) 732-737
4. Shanahan F. The host-microbe interface within the gut. Best Pract Res Clin Gastroenterol 16 6 (2002) 915-931
5. Gustafsson B.E. The physiological importance of the colonic microflora. Scand J Gastroenterol Suppl 77 (1982) 117-131
6. Suau A., Bonnet R., Sutren M., et al. Direct analysis of genes encoding 16S rRNA from complex communities reveals many novel molecular species within the human gut. Appl Environ Microbiol 65 11 (1999) 4799-4807
7. Tannock G.W. Molecular assessment of intestinal microflora. Am J Clin Nutr 73 Suppl. 2 (2001) 410S-414S
8. Backhed F., Ley R.E., Sonnenburg J.L., Peterson D.A., and Gordon J.I. Host-bacterial mutualism in the human intestine. Science 307 (2005) 1915-1920
9. O'Hara A.M., and Shanahan F. The gut flora as a forgotten organ. EMBO Rep 7 (2006) 688-693
10. Wostmann B.S. The germfree animal in nutritional studies. Annu Rev Nutr 1 (1981) 257-279
11. Cash H.L., and Hooper L.V. Commensal bacteria shape intestinal immune system development. ASM News 71 (2005) 77-83
12. Kelly D., Conway S., and Aminov R. Commensal gut bacteria: mechanisms of immune modulation. Trends Immunol 26 6 (2005) 326-333
13. Rakoff-Nahoum S., and Medzhitov R. Role of the innate immune system and host-commensal mutualism. Curr Top Microbiol Immunol 308 (2006) 1-18
14. Ley R.E., Peterson D.A., and Gordon J.I. Ecological and evolutionary forces shaping microbial diversity in the human intestine. Cell 124 4 (2006) 837-848
15. Winkler P., Ghadimi D., Schrezenmeir J., and Kraehenbuhl J.-P. Molecular and cellular basis of microflora-host interactions. J Nutr 137 3 (2007) 756S-772S
16. Turnbaugh P.J., Ley R.E., Mahowald M.A., Magrini V., Mardis E.R., and Gordon J.I. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444 7122 (2006) 1027-1131
17. Dumas M.-E., Barton R.H., Toye A., et al. Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice. Proc Natl Acad Sci USA 103 33 (2006) 12511-12516
18. Gill S.R., Pop M., Deboy R.T., et al. Metagenomic analysis of the human distal gut microbiome. Science 312 5778 (2006) 1355-1359
19. Blaut M., and Clavel T. Metabolic diversity of the intestinal microbiota: implications for health and disease. J Nutr 137 (2007) 751S-755S
20. Stappenbeck T.S., Hooper L.V., and Gordon J.I. Developmental regulation of intestinal angiogenesis by indigenous microbes via Paneth cells. Proc Natl Acad Sci USA 99 (2002) 15451-15455
21. Xu J., Bjursell M.K., Himrod J., et al. A genomic view of the human-bacteroides thetaiotaomicron symbiosis. Science 299 5615 (2003) 2074-2076
22. Kitajima S., Morimoto M., Sagara E., Shimizu C., and Ikeda Y. Dextran sodium sulfate-induced colitis in germ-free IQI/Jic mice. Exp Anim 50 (2001) 387-395
23. Rakoff-Nahoum S., Paglino J., Eslami-Varzaneh F., Edberg S., and Medzhitov R. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 118 (2004) 229-241
24. Cebra J.J. Influences of microbiota on intestinal immune system development. Am J Clin Nutr 69 5 (1999) 1046S-1051S
25. Macpherson A.J., and Harris N.L. Interactions between commensal intestinal bacteria and the immune system. Nat Rev Immunol 4 (2004) 478-485
26. MacDonald T.T., and Monteleone G. Immunity, inflammation, and allergy in the gut. Science 307 5717 (2005) 1920-1925
27. Mueller C., and Macpherson A.J. Layers of mutualism with commensal bacteria protect us from intestinal inflammation. Gut 55 (2006) 276-284
28. Mazmanian S.K., Liu C.H., Tzianabos A.O., and Kasper D.L. An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell 122 1 (2005) 107-118
29. Wang Q., McLoughlin R.M., Cobb B.A., et al. A bacterial carbohydrate links innate and adaptive responses through Toll-like receptor 2. J Exp Med 203 13 (2006) 2853-2863
30. Macpherson A.J., Hunziker L., McCoy K., and Lamarre A. IgA responses in the intestinal mucosa against pathogenic and non-pathogenic microorganisms. Microbes Infect 3 (2001) 1021-1035
31. Macpherson A.J., and Uhr T. Induction of protective IgA by intestinal dendritic cells carrying commensal bacteria. Science 303 (2004) 1662-1665
32. Bry L., Falk P.G., Midtvedt T., and Gordon J.I. A model of host-microbial interactions in an open mammalian ecosystem. Science 273 (1996) 1380-1383
33. Hooper L.V., Xu J., Falk P.G., Midtvedt T., and Gordon J.I. A molecular sensor that allows a gut commensal to control its nutrient foundation in a competitive ecosystem. Proc Natl Acad Sci USA 96 (1999) 9833-9838
34. Hooper L.V., Falk P.G., and Gordon J.I. Analyzing the molecular foundations of commensalism in the mouse intestine. Curr Opin Microbiol 3 (2000) 79-85
35. Hooper L.V., Stappenbeck T.S., Hong C.V., and Gordon J.I. Angiogenins: a new class of microbicidal proteins involved in innate immunity. Nat Immunol 4 (2003) 269-273
36. Cash H.L., Whitham C.V., Behrendt C.L., and Hooper L.V. Symbiotic bacteria direct expression of an intestinal bactericidal lectin. Science 313 (2006) 1126-1130
37. Hooper L.V., Wong M.H., Thelin A., Hansson L., Falk P.G., and Gordon J.I. Molecular analysis of commensal host-microbial relationships in the intestine. Science 291 (2001) 881-884
38. Rawls J.F., Mahowald M.A., Ley R.E., and Gordon J.I. Reciprocal gut microbiota transplants from zebrafish and mice to germ-free recipients reveal host habitat selection. Cell 127 2 (2006) 423-433
39. Ley R.E., Backhed F., Turnbaugh P., Lozupone C.A., Knight R.D., and Gordon J.I. Obesity alters gut microbial ecology. Proc Natl Acad Sci USA 102 (2005) 11070-11075
40. Wu L., Estrada O., Zaborina O., et al. Recognition of host immune activation by Pseudomonas aeruginosa. Science 309 5735 (2005) 774-777
41. Alverdy J., Zaborina O., and Wu L. The impact of stress and nutrition on bacterial-host interactions at the intestinal epithelial surface. Curr Opin Clin Nutr Metab Care 8 (2005) 205-209
42. Wijburg O.L.C., Uren T.K., Simpfendorfer K., Johansen F., Brandtzaeg P., and Strugnell R.A. Innate secretory antibodies protect against natural Salmonella typhimurium infection. J Exp Med 203 1 (2006) 21-26
43. Suzuki K., Meek B., Doi Y., et al. Aberrant expansion of segmented filamentous bacteria in IgA-deficient gut. Proc Natl Acad Sci USA 101 (2004) 1981-1986
44. Fagarasan S., Muramatsu M., Suzuki K., Nagaoka H., Hiai H., and Honjo T. Critical roles of activation-induced cytidine deaminase in the homeostasis of gut flora. Science 298 5597 (2002) 1424-1427
45. Boman H.G. Peptide antibiotics and their role in innate immunity. Annu Rev Immunol 13 (1995) 61-92
46. Zasloff M. Antimicrobial peptides of multicellular organisms. Nature 415 (2002) 389-395
47. Lehrer R.I., Bevins C.L., and Ganz T. Defensins and other antimicrobial peptides. In: Mestecky J., Bienstock J., Lamm M.E., Strober W.M., McGhee J., and Mayer L. (Eds). Mucosal immunology. 3rd ed. (2004), Academic Press, New York 95-110
48. Ganz T. Defensins: antimicrobial peptides of innate immunity. Nat Rev Immunol 3 9 (2003) 710-720
49. Lehrer R.I., Lichtenstein A.K., and Ganz T. Defensins: antimicrobial and cytotoxic peptides of mammalian cells. Annu Rev Immunol 11 (1993) 105-128
50. Shai Y. Mechanism of the binding, insertion and destabilization of phospholipid bilayer membranes by alpha-helical antimicrobial and cell non-selective membrane-lytic peptides. Biochim Biophys Acta 462 (1999) 55-70
51. Huang H.W. Peptide-lipid interactions and mechanisms of antimicrobial peptides. Novartis Found Symp 225 (1999) 188-200
52. Matsuzaki K. Why and how are peptide-lipid interactions utilized for self-defense? Magainins and tachyplesins as archetypes. Biochim Biophys Acta 1462 (1999) 1-10
53. Yang D., Chertov O., Bykovskaia S.N., et al. beta-defensins: linking innate and adaptive immunity through dendritic and T cell CCR6. Science 286 (1999) 525-528
54. Yang D., Chertov O., and Oppenheim J.J. The role of mammalian antimicrobial peptides and proteins in awakening of innate host defenses and adaptive immunity. Cell Mol Life Sci 58 (2001) 978-989
55. Lencer W.I., Cheung G., Strohmeier G.R., et al. Induction of epithelial chloride secretion by channel-forming cryptins 2 and 3. Proc Natl Acad Sci USA 94 (1997) 8585-8589
56. Merlin D., Yue G., Lencer W.I., Selsted M.E., and Madara J.L. Cryptdin-3 induces novel apical conductance(s) in Cl-secretory, including cystic fibrosis, epithelia. Am J Physiol Cell Physiol 280 (2001) C296-C302
57. Yue G., Merlin D., Selsted M.E., Lencer W.I., Madara J.L., and Eaton D.C. Cryptdin 3 forms anion selective channels in cytoplasmic membranes of human embryonic kidney cells. Am J Physiol Gastrointest Liver Physiol 282 (2002) G757-G765
58. Lin P.W., Simon P.O., Gewirtz A.T., et al. Paneth cell cryptdins act in vitro as apical paracrine regulators of the innate inflammatory response. J Biol Chem 279 (2004) 19902-19907
59. Ouellette A.J., Hsieh M.M., Nosek M.T., et al. Mouse Paneth cell defensins: primary structures and antibacterial activities of numerous cryptdin isoforms. Infect Immun 62 (1994) 5040-5047
60. Porter E., van Dam E., Valore E., and Ganz T. Broad spectrum antimicrobial activity of human intestinal defensin 5. Infect Immun 65 (1997) 2396-2401
61. Ghosh D., Porter E.M., Shen B., et al. Paneth cell trypsin is the processing enzyme for human defensin-5. Nat Immunol 3 (2002) 583-590
62. Tanabe H., Qu X., Weeks C.S., et al. Structure-activity determinants in Paneth cell alpha-defensins: loss-of-function in mouse cryptdin-4 by charge-reversal at arginine residue positions. J Biol Chem 279 (2004) 11976-11983
63. Wu Z., Ericksen B., Tucker K., Lubkowski J., and Lu W. Synthesis and characterization of human alpha-defensins 4-6. J Pept Res 64 3 (2004) 118-125
64. Ericksen B., Wu Z., Lu W., and Lehrer R.I. Antibacterial activity and specificity of the six human (alpha)-defensins. Antimicrob Agents Chemother 49 (2005) 269-275
65. Harder J., Bartels J., Christophers E., and Schroder J.M. A peptide antibiotic from human skin. Nature 387 (1997) 861
66. Harder J., Bartels J., Christophers E., and Schroder J.M. Isolation and characterization of human beta-defensin-3, a novel human inducible peptide antibiotic. J Biol Chem 276 (2001) 5707-5713
67. Valore E.V., Park C.H., Quayle A.J., Wiles K.R., McCray Jr. P.B., and Ganz T. Human β-defensin-1: an antimicrobial peptide of urogenital tissues. J Clin Invest 101 (1998) 1633-1642
68. Porter E.M., Bevins C.L., Ghosh D., and Ganz T. The multifaceted Paneth cell. Cell Mol Life Sci 59 (2002) 156-170
69. Ouellette A., and Bevins C.L. Paneth cell defensins and innate immunity of the small bowel. Inflamm Bowel Dis 7 (2001) 43-50
70. Wehkamp J., Chu H., Shen B., et al. Paneth cell antimicrobial peptides: topographical distribution and quantification in human gastrointestinal tissues. FEBS Lett 580 22 (2006) 5344-5350
71. Hornef M.F., Pütsep K., Karlsson J., Refai E., and Andersson M. Increased variability of intestinal antimicrobial peptides by covalent dimer formation. Nat Immunol 5 (2004) 836-843
72. Ouellette A.J., and Lualdi J.C. A novel mouse gene family coding for cationic, cysteine-rich peptides. J Biol Chem 265 (1990) 9831-9837
73. Putsep K., Axelsson L.G., Boman A., et al. Germ-free and colonized mice generate the same products from enteric prodefensins. J Biol Chem 275 (2000) 40478-40482
74. Mallow E.B., Harris A., Salzman N., et al. Human enteric defensins: gene structure and developmental expression. J Biol Chem 271 (1996) 4038-4045
75. Batlle E., Henderson J.T., Beghtel H., et al. Beta-catenin and TCF mediate cell positioning in the intestinal epithelium by controlling the expression of EphB/ephrinB. Cell 111 (2002) 251-263
76. van Es J., Jay P., Gregorieff A., et al. Wnt signalling induces maturation of Paneth cells in intestinal crypts. Nat Cell Biol 7 (2005) 381-386
77. Ouellette A.J., and Cordell B. Accumulation of abundant messenger ribonucleic acids during postnatal development of mouse small intestine. Gastroenterology 94 (1988) 114-121
78. Ouellette A.J., Greco R.M., James M., Frederick D., Naftilan J., and Fallon J.T. Developmental regulation of cryptdin, a corticostatin/defensin precursor mRNA in mouse small intestinal crypt epithelium. J Cell Biol 108 (1989) 1687-1695
79. Kelly P., Feakins R., Domizio P., et al. Paneth cell granule depletion in the human small intestine under infective and nutritional stress. Clin Exp Immunol 135 (2004) 303-309
80. Wehkamp J., Harder J., Weichenthal M., et al. NOD2 (CARD15) mutations in Crohńs disease are associated with diminished mucosal alpha-defensin expression. Gut 53 (2004) 1658-1664
81. Wehkamp J., Salzman N.H., Porter E., et al. Reduced Paneth cell alpha-defensins in ileal Crohn's disease. Proc Natl Acad Sci USA 102 (2005) 18129-18134
82. Bevins C.L. The Paneth cell and the innate immune response. Curr Opin Gastroenterol 20 (2004) 572-580
83. Qu X.D., Lloyd K.C., Walsh J.H., and Lehrer R.I. Secretion of type II phospholipase A2 and cryptdin by rat small intestinal Paneth cells. Infect Immun 64 (1996) 5161-5165
84. Ayabe T., Satchell D.P., Wilson C.L., Parks W.C., Selsted M.E., and Ouellette A.J. Secretion of microbicidal alpha-defensins by intestinal Paneth cells in response to bacteria. Nat Immunol 1 (2000) 113-118
85. Lala S., Ogura Y., Osborne C., et al. Crohn's disease and the NOD2 gene: a role for Paneth cells. Gastroenterology 125 (2003) 47-57
86. Rumio C., Besusso D., Palazzo M., et al. Degranulation of Paneth cells via toll-like receptor 9. Am J Pathol 165 (2004) 373-381
87. Kobayashi K.S., Chamaillard M., Ogura Y., et al. Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science 307 (2005) 731-734
88. Satoh Y., Habara Y., Ono K., and Kanno T. Carbamylcholine- and catecholamine-induced intracellular calcium dynamics of epithelial cells in mouse ileal crypts. Gastroenterology 108 (1995) 1345-1356
89. Ayabe T., Satchell D.P., Pesendorfer P., et al. Activation of Paneth cell alpha-defensins in mouse small intestine. J Biol Chem 277 (2002) 5219-5228
90. Wilson C.L., Ouellette A.J., Satchell D.P., et al. Regulation of intestinal alpha-defensin activation by the metalloproteinase matrilysin in innate host defense. Science 286 (1999) 113-117
91. Ouellette A.J. Paneth cell alpha-defensins: peptide mediators of innate immunity in the small intestine. Springer Semin Immunopathol (2005) 2
92. Selsted M.E., and Ouellette A.J. Mammalian defensins in the antimicrobial immune response. Nat Immunol 6 (2005) 551-557
93. Selsted M.E., Miller S.I., Henschen A.H., and Ouellette A.J. Enteric defensins: antibiotic peptide components of intestine host defense. J Cell Biol 118 (1992) 929-936
94. Shirafuji Y., Tanabe H., Satchell D.P., Henschen-Edman A., Wilson C.L., and Ouellette A.J. Structural determinants of procryptdin recognition and cleavage by matrix metalloproteinase-7. J Biol Chem 278 (2003) 7910-7919
95. Porter E.M., Poles M.A., Lee J.S., Naitoh J., Bevins C.L., and Ganz T. Isolation of human intestinal defensins from ileal neobladder urine. FEBS Lett 434 (1998) 272-276
96. Tanabe H., Yuan J., Zaragoza M.M., et al. Paneth cell alpha-defensins from rhesus macaque small intestine. Infect Immun 72 (2004) 1470-1478
97. Cunliffe R.N., Rose F.R., Keyte J., Abberley L., Chan W.C., and Mahida Y.R. Human defensin 5 is stored in precursor form in normal Paneth cells and is expressed by some villous epithelial cells and by metaplastic Paneth cells in the colon in inflammatory bowel disease. Gut 48 (2001) 176-185
98. Salzman N.H., Chou M.M., de Jong H., Liu L., Porter E.M., and Paterson Y. Enteric Salmonella infection inhibits Paneth cell antimicrobial peptide expression. Infect Immun 71 (2003) 1109-1115
99. Podolsky D.K. Inflamm Bowel Dis. N Engl J Med 347 (2002) 417-429
100. Sartor R.B. Intestinal microflora in human and experimental inflammatory bowel disease. Curr Opin Gastroenterol 17 (2001) 324-330
101. Marteau P., Lepage P., Mangin I., et al. Review article: gut flora and inflammatory bowel disease. Aliment Pharmacol Ther 4 (2004) 18-23
102. Strober W., Fuss I., and Mannon P. The fundamental basis of inflammatory bowel disease. J Clin Invest 117 3 (2007) 514-521
103. Janowitz H.D., Croen E.C., and Sachar D.B. The role of the fecal stream in Crohn's disease: an historical and analytic review. Inflamm Bowel Dis 4 (1998) 29-39
104. Harper P.H., Truelove S.C., Lee E.C., Kettlewell M.G., and Jewell D.P. Split ileostomy and ileocolostomy for Crohn's disease of the colon and ulcerative colitis: a 20 year survey. Gut 24 (1983) 106-113
105. Rutgeerts P., Goboes K., Peeters M., et al. Effect of faecal stream diversion on recurrence of Crohn's disease in the neoterminal ileum. Lancet 338 (1991) 771-774
106. Prantera C., Zannoni F., Scribano M.L., et al. An antibiotic regimen for the treatment of active Crohn's disease: a randomized, controlled clinical trial of metronidazole plus ciprofloxacin. Am J Gastroenterol 91 (1996) 328-332
107. Rutgeerts P., Hiele M., Geboes K., et al. Controlled trial of metronidazole treatment for prevention of Crohn's recurrence after ileal resection. Gastroenterology 108 (1995) 1617-1621
108. Arnold G.L., Beaves M.R., Pryjdun V.O., and Mook W.J. Preliminary study of ciprofloxacin in active Crohn's disease. Inflamm Bowel Dis 8 (2002) 10-15
109. D'Haens G.R., Geboes K., Peeters M., Baert F., Penninckx F., and Rutgeerts P. Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum. Gastroenterology 114 (1998) 262-267
110. Neut C., Bulois P., Desreumaux P., et al. Changes in the bacterial flora of the neoterminal ileum after ileocolonic resection for Crohn's disease. Am J Gastroenterol 97 (2002) 939-946
111. Duchmann R., May E., Heike M., Knolle P., Neurath M., and Meyer zum Buschenfelde K.H. T cell specificity and cross reactivity towards enterobacteria, bacteroides, bifidobacterium, and antigens from resident intestinal flora in humans. Gut 44 (1999) 812-818
112. Strober W., Fuss I.J., and Blumberg R.S. The immunology of mucosal models of inflammation. Annu Rev Immunol 20 (2002) 495-549
113. Elson C.O., Cong Y., McCracken V.J., Dimmitt R.A., Lorenz R.G., and Weaver C.T. Experimental models of inflammatory bowel disease reveal innate, adaptive, and regulatory mechanisms of host dialogue with the microbiota. Immunol Rev 206 (2005) 260-276
114. Kuhn R., Lohler J., Rennick D., Rajewsky K., and Muller W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75 (1993) 263-274
115. Sadlack B., Merz H., Schorle H., Schimpl A., Feller A.C., and Horak I. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell 75 (1993) 253-261
116. Dianda L., Hanby A.M., Wright N.A., Sebesteny A., Hayday A.C., and Owen M.J. T cell receptor-alpha beta-deficient mice fail to develop colitis in the absence of a microbial environment. Am J Pathol 150 (1997) 91-97
117. Mombaerts P., Mizoguchi E., Grusby M.J., Glimcher L.H., Bhan A.K., and Tonegawa S. Spontaneous development of inflammatory bowel disease in T cell receptor mutant mice. Cell 75 (1993) 274-282
118. Rath H.C., Herfarth H.H., Ikeda J.S., et al. Normal luminal bacteria, especially Bacteroides species, mediate chronic colitis, gastritis, and arthritis in HLA-B27/human beta2 microglobulin transgenic rats. J Clin Invest 98 4 (1996) 945-953
119. Eckburg P.B., and Relman D.A. The role of microbes in Crohn's disease. Clin Infect Dis 44 2 (2007) 256-262
120. Chacon O., Bermudez L.E., and Barletta R.G. Johne's disease, inflammatory bowel disease, and Mycobacterium paratuberculosis. Annu Rev Microbiol 58 (2004) 329-363
121. Darfeuille-Michaud A., Boudeau J., Bulois P., et al. High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease. Gastroenterology 127 2 (2004) 412-421
122. Darfeuille-Michaud A., Neut C., Barnich N., et al. Presence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn's disease. Gastroenterology 115 (1998) 1405-1413
123. Sokol H., Seksik P., Rigottier-Gois L., et al. Specificities of the fecal microbiota in inflammatory bowel disease. Inflamm Bowel Dis 12 2 (2006) 106-111
124. Hugot J.P., Chamaillard M., Zouali H., et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411 (2001) 599-603
125. Ogura Y., Bonen D.K., Inohara N., et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 411 (2001) 603-606
126. Bonen D.K., and Cho J.H. The genetics of inflammatory bowel disease. Gastroenterology 124 (2003) 521-531
127. Hugot J.P. Genetic origin of IBD. Inflamm Bowel Dis 10 (2004) S11-S15
128. Fellermann K., Wehkamp J., Herrlinger K.R., and Stange E.F. Crohn's disease: a defensin deficiency syndrome?. Eur J Gastroenterol Hepatol 15 (2003) 627-634
129. Henry M.C.W., and Moss R.L. Current issues in the management of necrotizing enterocolitis. Semin Perinatol 28 3 (2004) 221-233
130. Lin P.W., and Stoll B.J. Necrotising enterocolitis. Lancet 368 9543 (2006) 1271-1283
131. Neu J., Chen M., and Beierle E. Intestinal innate immunity: how does it relate to the pathogenesis of necrotizing enterocolitis. Semin Pediatr Surg 14 3 (2005) 137-144
132. Tannock G.W. What immunologists should know about bacterial communities of the human bowel. Semin Immunol 19 2 (2007) 94-105
133. Westerbeek E.A., van den Berg A., Lafeber H.N., Knol J., Fetter W.P., and van Elburg R.M. The intestinal bacterial colonisation in preterm infants: a review of the literature. Clin Nutr 25 3 (2006) 361-368
134. Nanthakumar N.N., Young C., Ko J.S., et al. Glucocorticoid responsiveness in developing human intestine: possible role in prevention of necrotizing enterocolitis. Am J Physiol Gastrointest Liver Physiol 288 1 (2005) G85-G92
135. Dinsdale D., and Biles B. Postnatal changes in the distribution and elemental composition of Paneth cells in normal and corticosteroid-treated rats. Cell Tissue Res 246 1 (1986) 183-187
136. Clark J.A., Doelle S.M., Halpern M.D., et al. Intestinal barrier failure during experimental necrotizing enterocolitis: protective effect of EGF treatment. Am J Physiol Gastrointest Liver Physiol 291 5 (2006) G938-G949
137. Lin H.C., Su B.H., Chen A.C., et al. Oral probiotics reduce the incidence and severity of necrotizing enterocolitis in very low birth weight infants. Pediatrics 115 1 (2005) 1-4
138. Bin-Nun A., Bromiker R., Wilschanski M., et al. Oral probiotics prevent necrotizing enterocolitis in very low birth weight neonates. J Pediatr 147 2 (2005) 192-196
139. Boehm G., Jelinek J., Stahl B., et al. Prebiotics in infant formulas. J Clin Gastroenterol 38 Suppl. 6 (2004) S76-S79
140. Ganz T. Paneth cells-guardians of the gut cell hatchery. Nat Immunol 1 (2000) 99-100
141. Porter E., Liu L., Oren A., Anton P., and Ganz T. Localization of human intestinal defensin 5 in Paneth cell granules. Infect Immun 65 (1997) 2389-2395
142. Salzman N.H., Ghosh D., Huttner K.M., Paterson Y., and Bevins C.L. Protection against enteric salmonellosis in transgenic mice expressing a human intestinal defensin. Nature 422 (2003) 522-526
143. Salzman N.H., and Bevins C.L. Negative interactions with the microbiota (IBD). In: Huffnagle G., and Noverr M. (Eds). GI microbiota and regulation of the immune system (2007), Landes Bioscience, Georgetown, TX